Skip to main content
Signal8
Falk Dan Michael profile photo

Dan Michael Falk

CIK: 0001966097

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (50.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

NICE Ltd. logo
NICE

NICE Ltd.

Director
Innoviz Technologies Ltd. logo
INVZ

Innoviz Technologies Ltd.

Director
Evogene Ltd. logo
EVGN

Evogene Ltd.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • NICE Ltd. logo
    NICE

    NICE Ltd.

    Jun 3, 2026
    Exercise(M)
    Direct
    696 shares at avg. $0.29$203.858
  • Innoviz Technologies Ltd. logo
    INVZ

    Innoviz Technologies Ltd.

    May 13, 2026
    Award(A)
    Direct
    110.7K shares-

1-2 of 2

About Falk Dan Michael

Falk Dan Michael (SEC CIK 0001966097) files insider reports with the SEC as Director of NICE Ltd. (NICE), Director of Innoviz Technologies Ltd. (INVZ) and Director of Evogene Ltd. (EVGN).

Signal8 holds 5 ownership filings by Falk Dan Michael (3 Form 3, 2 Form 4), filed between Mar 18, 2026 and Jun 4, 2026. Those filings report 2 transactions, from May 13, 2026 to Jun 3, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Falk Dan Michael's filings is in HOBOKEN, NJ.

Recent filings by Falk Dan Michael

  • Jun 3, 2026: Option exercise of NICE shares (Form 4, code M).
  • May 13, 2026: Grant or award of INVZ shares (Form 4, code A).

Other insiders filing for NICE Ltd. (NICE)

How to read Form 4 transaction codes